rs144901788
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_002529.4(NTRK1):c.1474G>A(p.Glu492Lys) variant causes a missense change. The variant allele was found at a frequency of 0.00069 in 1,613,264 control chromosomes in the GnomAD database, including 1 homozygotes. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.00038 ( 0 hom., cov: 31)
Exomes 𝑓: 0.00072 ( 1 hom. )
Consequence
NTRK1
NM_002529.4 missense
NM_002529.4 missense
Scores
5
10
2
Clinical Significance
Conservation
PhyloP100: 6.64
Genes affected
NTRK1 (HGNC:8031): (neurotrophic receptor tyrosine kinase 1) This gene encodes a member of the neurotrophic tyrosine kinase receptor (NTKR) family. This kinase is a membrane-bound receptor that, upon neurotrophin binding, phosphorylates itself and members of the MAPK pathway. The presence of this kinase leads to cell differentiation and may play a role in specifying sensory neuron subtypes. Mutations in this gene have been associated with congenital insensitivity to pain, anhidrosis, self-mutilating behavior, cognitive disability and cancer. Alternate transcriptional splice variants of this gene have been found, but only three have been characterized to date. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PM2
?
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
NTRK1 | NM_002529.4 | c.1474G>A | p.Glu492Lys | missense_variant | 12/17 | ENST00000524377.7 | |
NTRK1 | NM_001012331.2 | c.1456G>A | p.Glu486Lys | missense_variant | 11/16 | ||
NTRK1 | NM_001007792.1 | c.1366G>A | p.Glu456Lys | missense_variant | 12/17 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
NTRK1 | ENST00000524377.7 | c.1474G>A | p.Glu492Lys | missense_variant | 12/17 | 1 | NM_002529.4 | P4 |
Frequencies
GnomAD3 genomes ? AF: 0.000376 AC: 57AN: 151796Hom.: 0 Cov.: 31
GnomAD3 genomes
?
AF:
AC:
57
AN:
151796
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000454 AC: 114AN: 250934Hom.: 0 AF XY: 0.000361 AC XY: 49AN XY: 135648
GnomAD3 exomes
AF:
AC:
114
AN:
250934
Hom.:
AF XY:
AC XY:
49
AN XY:
135648
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000723 AC: 1056AN: 1461468Hom.: 1 Cov.: 35 AF XY: 0.000696 AC XY: 506AN XY: 727070
GnomAD4 exome
AF:
AC:
1056
AN:
1461468
Hom.:
Cov.:
35
AF XY:
AC XY:
506
AN XY:
727070
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome ? AF: 0.000376 AC: 57AN: 151796Hom.: 0 Cov.: 31 AF XY: 0.000324 AC XY: 24AN XY: 74098
GnomAD4 genome
?
AF:
AC:
57
AN:
151796
Hom.:
Cov.:
31
AF XY:
AC XY:
24
AN XY:
74098
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
0
ALSPAC
AF:
AC:
3
ESP6500AA
AF:
AC:
3
ESP6500EA
AF:
AC:
10
ExAC
?
AF:
AC:
63
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:7Benign:1
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
not provided Uncertain:3
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Jun 05, 2023 | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 22302274, 27058611, 32707200, 34426522, 33235206, 35101157) - |
Uncertain significance, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Mar 01, 2024 | NTRK1: PM2, PP3 - |
Uncertain significance, criteria provided, single submitter | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Apr 01, 2019 | - - |
Hereditary insensitivity to pain with anhidrosis Uncertain:2Benign:1
Uncertain significance, no assertion criteria provided | clinical testing | Natera, Inc. | Sep 16, 2020 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Invitae | Jan 25, 2024 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Oct 25, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Jun 02, 2023 | Variant summary: NTRK1 c.1456G>A (p.Glu486Lys) results in a conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.00045 in 250934 control chromosomes (gnomAD). This frequency is not significantly higher than estimated for a pathogenic variant in NTRK1 causing Hereditary Insensitivity To Pain With Anhidrosis (0.00045 vs 0.0011), allowing no conclusion about variant significance. c.1456G>A has been reported in the literature in individuals affected with sensory and autonomic neuropathy, presumed ocular histoplasmosis syndrome, as well as in a large pedigree, in which bipolar disorder co-segregated with autosomal dominant tubulointerstitial kidney disease (Davidson_2012, Li_2020, Nakajima_2020). These reports do not provide unequivocal conclusions about association of the variant with Hereditary Insensitivity To Pain With Anhidrosis. At least one functional study showed E492K NSCs (neural stem cells) had reduced neurite outgrowth and a conditional knock-in mouse line showed depression-like behavior in the tail suspension test following challenge by physostigmine, a cholinesterase inhibitor (Nakajima_2020). The following publications have been ascertained in the context of this evaluation (PMID: 22302274, 32707200, 33235206). Five ClinVar submitters (evaluation after 2014) cite this variant as uncertain significance (n=4) and likely benign (n=1). Based on the evidence outlined above, the variant was classified as uncertain significance. - |
Charcot-Marie-Tooth disease Uncertain:1
Uncertain significance, no assertion criteria provided | literature only | Inherited Neuropathy Consortium | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Uncertain
D
BayesDel_noAF
Pathogenic
Cadd
Pathogenic
Dann
Pathogenic
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Pathogenic
D;D;D;D
M_CAP
Benign
D
MetaRNN
Uncertain
D;D;D;D
MetaSVM
Uncertain
D
MutationTaster
Benign
D;D;D;D
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D;D;D;D
REVEL
Pathogenic
Sift
Uncertain
D;D;D;D
Sift4G
Uncertain
D;D;D;D
Polyphen
0.069, 1.0
.;B;D;.
Vest4
MVP
MPC
0.36
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at